We examined patient characteristics, disease severity, and enteral nutrition formula use in relation to feeding intolerance and healthcare resource utilization.
The purpose is to provide a descriptive analysis of patients who received parenteral nutrition with high mixed lipid and low dextrose content versus parenteral nutrition with lower 100% soybean oil lipid and high dextrose content.
This review summarizes recent evidence regarding glucose control in critical illness.
We report a case of severe and prolonged hyperglycemia that occurred in a patient after receiving a one-time dose of lanreotide, who had previously been stable on octreotide and did not have a history of diabetes mellitus
Evaluation of the association of glycemic-control formulas with measurements of glycemic control and clinical outcomes compared to standard enteral formulas in critically ill patients.
The aim was to study the impact of a minimal enteral feeding on the possible early metabolic complications of PN in a cohort of preterms.
We aim to assess the prevalence of hyperglycemia induced by total parenteral nutrition and identify its risk factors in hospitalized adult patients.
Letter to the Editor regarding article on INSUPAR trial associating the use of subcutaneous glargine insulin compared to regular insulin added to total parenteral nutrition in non-critically ill patients with type 2 diabetes mellitus.
The study compares clinical outcomes between patients on volume-based tube feeding vs conventional rate-based tube feeding.
The objective was to identify the predictive factors of hyperglycemia in patients receiving parenteral nutrition.